T
TALMedora Editorial
Ketamine's Depression Hype Is Being Questioned by New…
Ketamine's Depression Hype Is Being Questioned by New Research Ketamine has been hailed as a fast-acting, effective treatment for major depression, but new research questions whether the drug lives up to its hype. This is medicine doing what medicine should do: subjecting even celebrated breakthroughs to continued scrutiny. Ketamine and its FDA-approved derivative esketamine (Spravato) generated enormous excitement as the first genuinely novel antidepressant mechanism in
Create an account to read the full story.
Join TALMedora to get full access
Already have an account?
Comments (0)
No comments yet. Be the first to comment!